相似文献
1
Use of a new dual-antigen enzyme-linked immunosorbent assay to detect and characterize the human antibody response to the human immunodeficiency virus type 2 envelope gp125 and gp36 glycoproteins.
J Clin Microbiol. 2006 Feb;44(2):607-11. doi: 10.1128/JCM.44.2.607-611.2006.
2
3
[Use of a synthetic peptide of HIV-2 glycoprotein 36 in antigen mixtures for the immunodiagnosis of HIV types 1 and 2].
Enferm Infecc Microbiol Clin. 2015 Dec;33(10):663-5. doi: 10.1016/j.eimc.2014.12.004. Epub 2015 Jan 29.
4
Characterization of monoclonal antibodies to human immunodeficiency virus type 2 envelope glycoproteins.
AIDS Res Hum Retroviruses. 1994 Dec;10(12):1659-67. doi: 10.1089/aid.1994.10.1659.
5
Potent neutralizing serum immunoglobulin A (IgA) in human immunodeficiency virus type 2-exposed IgG-seronegative individuals.
J Virol. 2004 Jul;78(13):7016-22. doi: 10.1128/JVI.78.13.7016-7022.2004.
6
The use of a chimera HIV-1/HIV-2 envelope protein for immunodiagnosis of HIV infection: its expression and purification in E. coli by use of a translation initiation site within HIV-1 env gene.
Biochem Mol Biol Int. 1998 Oct;46(3):607-17. doi: 10.1080/15216549800204132.
7
Designing of novel antigenic peptide cocktail for the detection of antibodies to HIV-1/2 by ELISA.
J Immunol Methods. 2013 Jan 31;387(1-2):157-66. doi: 10.1016/j.jim.2012.10.009. Epub 2012 Oct 23.
8
Human neutralizing human immunodeficiency virus type 2-specific Fab molecules generated by phage display.
J Gen Virol. 1999 Aug;80 ( Pt 8):1987-1993. doi: 10.1099/0022-1317-80-8-1987.
9
Identification of B-cell antigenic sites on HIV-2 gp125.
J Acquir Immune Defic Syndr (1988). 1992;5(2):177-87.
10
Strongly enhanced sensitivity of a direct anti-HIV-1/-2 assay in seroconversion by incorporation of HIV p24 ag detection: a new generation vironostika HIV Uni-Form II.
J Virol Methods. 1998 Dec;76(1-2):59-71. doi: 10.1016/s0166-0934(98)00126-8.
引用本文的文献
1
Low Postseroconversion CD4 T-cell Level Is Associated with Faster Disease Progression and Higher Viral Evolutionary Rate in HIV-2 Infection.
mBio. 2019 Jan 8;10(1):e01245-18. doi: 10.1128/mBio.01245-18.
2
HIV-2 and its role in conglutinated approach towards Acquired Immunodeficiency Syndrome (AIDS) Vaccine Development.
Springerplus. 2013 Dec;2(1):7. doi: 10.1186/2193-1801-2-7. Epub 2013 Jan 11.
3
Evolutionary and structural features of the C2, V3 and C3 envelope regions underlying the differences in HIV-1 and HIV-2 biology and infection.
PLoS One. 2011 Jan 20;6(1):e14548. doi: 10.1371/journal.pone.0014548.
4
Potent and broadly reactive HIV-2 neutralizing antibodies elicited by a vaccinia virus vector prime-C2V3C3 polypeptide boost immunization strategy.
J Virol. 2010 Dec;84(23):12429-36. doi: 10.1128/JVI.01102-10. Epub 2010 Sep 15.
5
Inexpensive designer antigen for anti-HIV antibody detection with high sensitivity and specificity.
Clin Vaccine Immunol. 2010 Mar;17(3):335-41. doi: 10.1128/CVI.00283-09. Epub 2010 Jan 20.
6
The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients.
Retrovirology. 2008 Sep 8;5:78. doi: 10.1186/1742-4690-5-78.
本文引用的文献
1
Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries.
AIDS. 2005 May;19 Suppl 2:S25-30. doi: 10.1097/01.aids.0000172874.90133.7a.
2
Indian primary HIV-2 isolates and relationship between V3 genotype, biological phenotype and coreceptor usage.
Virology. 2005 Jun 20;337(1):68-75. doi: 10.1016/j.virol.2005.04.008.
3
Detection of acute infections during HIV testing in North Carolina.
N Engl J Med. 2005 May 5;352(18):1873-83. doi: 10.1056/NEJMoa042291.
4
Antigenic conservation and immunogenicity of the HIV coreceptor binding site.
J Exp Med. 2005 May 2;201(9):1407-19. doi: 10.1084/jem.20042510.
5
Phylogenetic demonstration of two cases of perinatal human immunodeficiency virus type 2 infection diagnosed in adulthood.
AIDS Res Hum Retroviruses. 2004 Dec;20(12):1373-6. doi: 10.1089/aid.2004.20.1373.
6
Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays.
J Virol Methods. 2004 Dec 15;122(2):185-94. doi: 10.1016/j.jviromet.2004.08.018.
7
The natural history of HIV-1 and HIV-2 infections in adults in Africa: a literature review.
Bull World Health Organ. 2004 Jun;82(6):462-9.
8
Potent neutralizing serum immunoglobulin A (IgA) in human immunodeficiency virus type 2-exposed IgG-seronegative individuals.
J Virol. 2004 Jul;78(13):7016-22. doi: 10.1128/JVI.78.13.7016-7022.2004.
9
Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set point.
Blood. 2004 Sep 15;104(6):1784-92. doi: 10.1182/blood-2004-01-0251. Epub 2004 Jun 8.
10
Multicenter evaluation of a new, automated enzyme-linked immunoassay for detection of human immunodeficiency virus-specific antibodies and antigen.
J Clin Microbiol. 2004 Jan;42(1):21-9. doi: 10.1128/JCM.42.1.21-29.2004.
Zotero 插件